Royal Bank Of Canada Exagen Inc. Transaction History

Royal Bank Of Canada

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.36 - $2.05 $202 - $305	149 Added 169.32%	237 $0
Q1 2024 Nov 05, 2024	SELL	$1.42 - $2.3 $211 - $342	-149 Reduced 62.87%	88 $0
Q1 2024 May 15, 2024	SELL	$1.42 - $2.3 $644 - $1,044	-454 Reduced 83.76%	88 $0
Q4 2023 Feb 14, 2024	SELL	$1.45 - $2.39 $4,589 - $7,564	-3,165 Reduced 85.38%	542 $1,000
Q3 2023 Nov 14, 2023	BUY	$2.24 - $2.93 $1,263 - $1,652	564 Added 17.94%	3,707 $8,000
Q2 2023 Aug 14, 2023	BUY	$2.36 - $3.48 $7,025 - $10,359	2,977 Added 1793.37%	3,143 $9,000
Q1 2023 May 15, 2023	SELL	$2.23 - $2.9 $2 - $2	-1 Reduced 0.6%	166 $0
Q4 2022 Feb 14, 2023	SELL	$2.1 - $3.4 $128 - $207	-61 Reduced 26.75%	167 $0
Q3 2022 Nov 14, 2022	BUY	$2.69 - $8.68 $252 - $815	94 Added 70.15%	228 $1,000
Q2 2022 Aug 15, 2022	SELL	$4.18 - $7.74 $2,721 - $5,038	-651 Reduced 82.93%	134 $1,000
Q1 2022 May 16, 2022	SELL	$7.12 - $11.06 $10,131 - $15,738	-1,423 Reduced 64.45%	785 $6,000
Q4 2021 Feb 14, 2022	BUY	$8.97 - $14.08 $8,198 - $12,869	914 Added 70.63%	2,208 $26,000
Q3 2021 Nov 15, 2021	BUY	$10.25 - $15.21 $5,617 - $8,335	548 Added 73.46%	1,294 $18,000
Q2 2021 Aug 16, 2021	BUY	$12.4 - $17.92 $9,250 - $13,368	746 New	746 $11,000

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $89.8M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.